RGEN logo

Repligen (RGEN)

Profile

Full Name

Repligen Corporation

Ticker Symbol

RGEN

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

April 29, 1986

Indexes

Not included

Website

http://www.repligen.com

Employees

1778

Key Details

Price

$132.00

Market Cap

$7.41B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$634.44M(+0.33% YoY)

Annual EPS

-$0.46(-173.02% YoY)

PE Ratio

-

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$132.00
RGEN price is $132.00

Price All-time High

$324.21
RGEN price is currently -59.29% below its historical high of $324.21

Price Today Change

-0.28%
RGEN price is down -0.28% today

Price YTD Change

-8.3%
RGEN price is down -8.3% since January 1st

Price 1-year Change

-28.23%
RGEN price is down -28.23% year-on-year

Price 3-year Change

-29.82%
RGEN price is down -29.82% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$7.41B
RGEN market capitalization is $7.41 billion

Market Cap 3-year Change

-28.91%
RGEN market capitalization is down -28.91% over the past 3 years

Market Cap All-time High

$17.82B
RGEN market capitalization is currently -58.42% below its historical high of $17.82 billion

Market Cap Sector Rank

91.07%
RGEN market capitalization is higher than 91.07% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.56%
RGEN shares outstanding is up +0.56% year-on-year

Shares Outstanding 3-Year Change

+1.48%
RGEN shares outstanding is up +1.48% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.34
RGEN beta is 1.34

200-day SMA

$145.59
RGEN price is currently -9.33% below its 200-day simple moving average

50-day SMA

$154.53
RGEN price is currently -14.58% below its 50-day simple moving average

RSI

37.13
RGEN 14-day relative strength index is 37.13

Volume

1.16
RGEN 30-day relative volume is 1.16

ATR

$7.17
RGEN average true range is $7.17

10-day Historical Volatility

42.82%
RGEN 10-day historical volatility is 42.82%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$634.44M
RGEN annual revenue is $634.44 million

Revenue Analysts Estimate

$698.38M
RGEN annual revenue is currently -9.16% lower than the consensus analysts' forecast

Revenue 1-year Change

+0.33%
RGEN annual revenue is up +0.33% year-on-year

Revenue Sector Rank

76.02%
RGEN annual revenue is higher than 76.02% of companies in Healthcare sector

EPS

EPS

-$0.46
RGEN annual earnings per share is -$0.46

EPS Analysts Estimate

$1.71
RGEN annual earnings per share is currently -126.88% lower than the consensus analysts' forecast

EPS 1-year Change

-173.02%
RGEN annual earnings per share is down -173.02% year-on-year

EPS Sector Rank

70.79%
RGEN annual earnings per share is higher than 70.79% of companies in Healthcare sector

Profit

Gross Profit

$274.64M
RGEN annual gross profit is $274.64 million

Gross Margin

43.29%
RGEN annual gross profit margin is 43.29%

Operating Profit

-$31.92M
RGEN annual operating income is -$31.92 million

Operating Margin

-5.03%
RGEN annual operating profit margin is -5.03%

Net Income

-$25.51M
RGEN annual net profit is -$25.51 million

Net Margin

-4.02%
RGEN annual net profit margin is -4.02%

Expenses

Total Expenses

$666.36M
RGEN annual total expenses is $666.36 million

Operating Expenses

$306.57M
RGEN annual total operating expenses is $306.57 million

Cost Of Goods Sold

$359.79M
RGEN annual cost of goods sold is $359.79 million

Selling, General & Administrative Expenses

$263.37M
RGEN annual SGA is $263.37 million

Depreciation And Amortization

$86.56M
RGEN annual depreciation & amortization is $86.56 million

Interest Expense

$20.73M
RGEN annual interest expense is $20.73 million

Income Tax

-$1.52M
RGEN annual income tax is -$1.52 million

EBIT & EBITDA

EBIT

-$6.30M
RGEN annual earnings before interest & taxes is -$6.30 million

EBITDA

-$6.30M
RGEN annual EBITDA is -$6.30 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$2.83B
RGEN annual total assets is $2.83 billion

Non Current Assets

$1.76B
RGEN annual long term assets is $1.76 billion

Current Assets

$1.07B
RGEN annual total current assets is $1.07 billion

Cash And Cash Equivalents

$757.36M
RGEN annual cash & cash equivalents is $757.36 million

Accounts Receivable

$134.12M
RGEN annual accounts receivable is $134.12 million

Inventory

$142.96M
RGEN annual inventory is $142.96 million

Liabilities

Total Liabilities

$856.95M
RGEN annual total liabilities is $856.95 million

Long Term Liabilities

$730.16M
RGEN annual total long term liabilities is $730.16 million

Current Liabilities

$126.79M
RGEN annual total current liabilities is $126.79 million

Accounts Payable

$32.13M
RGEN annual accounts payable is $32.13 million

Debt

Total Debt

$686.25M
RGEN annual total debt is $686.25 million

Total Debt 1-year Change

-3.59%
RGEN annual total debt is down -3.59% year-on-year

Long Term Debt

$671.14M
RGEN annual long term debt is $671.14 million

Short Term Debt

$15.10M
RGEN annual short term debt is $15.10 million

Equity & Capital

Shareholders Equity

$1.97B
RGEN annual stockholders equity is $1.97 billion

Book Value

$1.97B
RGEN annual book value is $1.97 billion

Retained Earnings

$407.35M
RGEN annual retained earnings is $407.35 million

Working Capital

$939.25M
RGEN annual working capital is $939.25 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$175.39M
RGEN annual cash flow from operations is $175.39 million

Cash From Operations 1-year Change

+53.97%
RGEN annual cash flow from operations is up +53.97% year-on-year

Cash From Investing

-$86.38M
RGEN annual cash flow from investing activities is -$86.38 million

Cash From Investing 1-year Change

+29.93%
RGEN annual cash flow from investing activities is up +29.93% year-on-year

Cash From Financing

-$82.90M
RGEN annual cash flow from financing activities is -$82.90 million

Cash From Financing 1-year Change

-133.3%
RGEN annual cash flow from financing activities is down -133.3% year-on-year

CAPEX

CAPEX

$32.91M
RGEN annual capital expenditures is $32.91 million

CAPEX 1-year Change

-15.6%
RGEN annual capital expenditures is down -15.6% year-on-year

Free Cash Flow

Free Cash Flow

$142.49M
RGEN annual free cash flow is $142.49 million

Free Cash Flow 1-year Change

+90.16%
RGEN annual free cash flow is up +90.16% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

43.29%
RGEN annual gross profit margin is 43.29%

Operating Margin

-5.03%
RGEN annual operating profit margin is -5.03%

Net Margin

-4.02%
RGEN annual net profit margin is -4.02%

ROA & ROE

ROA

-0.90%
RGEN annual return on assets is -0.90%

ROE

-1.30%
RGEN annual return on equity is -1.30%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
RGEN price to earnings ratio value is unknown

PE Ratio Sector Rank

-
RGEN price to earnings ratio is unknown

PB Ratio

PB Ratio

3.76
RGEN price to book ratio is 3.76

PB Ratio Sector Rank

76.59%
RGEN price to book ratio is higher than 76.59% of companies in Healthcare sector

PS Ratio

PS Ratio

11.68
RGEN price to sales ratio is 11.68

PS Ratio Sector Rank

81.04%
RGEN price to sales ratio is higher than 81.04% of companies in Healthcare sector

Enterprise value

Enterprise Value

$7.34B
RGEN enterprise value is $7.34 billion

Enterprise Value Sector Rank

90.13%
RGEN enterprise value is higher than 90.13% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

163.12
RGEN EV/EBITDA is 163.12

EV/EBITDA Sector Rank

99.3%
RGEN EV/EBITDA is higher than 99.3% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

8.41
RGEN annual current ratio is 8.41

Quick Ratio

7.28
RGEN annual quick ratio is 7.28

Leverage

Debt To Equity

0.27
RGEN annual debt to equity ratio is 0.27

Interest Coverage Ratio

-0.30
RGEN annual interest coverage ratio is -0.30

Risk & Stability

Piotroski F-Score

3
RGEN piotroski f-score is 3

Altman Z-Score

6.01
RGEN altman z-score is 6.01

Analyst ratings

Recent major analysts updates

Mar 18, 25 Evercore ISI Group
In-Line
Feb 21, 25 RBC Capital
Outperform
Feb 21, 25 JP Morgan
Overweight
Feb 21, 25 HC Wainwright & Co.
Buy
Feb 21, 25 Canaccord Genuity
Hold
Jan 23, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Dec 17, 24 Canaccord Genuity
Hold
Nov 14, 24 Wolfe Research
Peer Perform
Sep 26, 24 RBC Capital
Outperform

Institutional Ownership

Similar stocks

JAZZ logo
Jazz Pharmaceuticals (JAZZ)
ROIV logo
Roivant Sciences (ROIV)
HQY logo
HealthEquity (HQY)
ENSG logo
Ensign (ENSG)
MDGL logo
Madrigal Pharmaceuticals (MDGL)
HALO logo
Halozyme Therapeutics (HALO)
TEM logo
Tempus AI (TEM)
CRL logo
Charles River Laboratories International (CRL)
HSIC logo
Henry Schein (HSIC)
  • What is the ticker symbol for Repligen?
  • Does Repligen pay dividends?
  • What sector is Repligen in?
  • What industry is Repligen in?
  • What country is Repligen based in?
  • When did Repligen go public?
  • Is Repligen in the S&P 500?
  • Is Repligen in the NASDAQ 100?
  • Is Repligen in the Dow Jones?
  • When was Repligen's last earnings report?
  • When does Repligen report earnings?
  • Should I buy Repligen stock now?

What is the ticker symbol for Repligen?

The ticker symbol for Repligen is NASDAQ:RGEN

Does Repligen pay dividends?

No, Repligen does not pay dividends

What sector is Repligen in?

Repligen is in the Healthcare sector

What industry is Repligen in?

Repligen is in the Medical Instruments & Supplies industry

What country is Repligen based in?

Repligen is headquartered in United States

When did Repligen go public?

Repligen's initial public offering (IPO) was on April 29, 1986

Is Repligen in the S&P 500?

No, Repligen is not included in the S&P 500 index

Is Repligen in the NASDAQ 100?

No, Repligen is not included in the NASDAQ 100 index

Is Repligen in the Dow Jones?

No, Repligen is not included in the Dow Jones index

When was Repligen's last earnings report?

Repligen's most recent earnings report was on Feb 20, 2025

When does Repligen report earnings?

The next expected earnings date for Repligen is May 1, 2025

Should I buy Repligen stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page